A Real-World Study on the Day and Night-Time Symptoms Among Greek COPD Patients Who Recently Initiated Treatment with Dual Bronchodilation: The DANICO Study.

Konstantinos Kostikas Katerina DimakouKonstantinos GourgoulianisMina GagaDimosthenis PapapetrouGeorgios TsoukalasPanagiotis ChatziapostolouAntonios AntoniadisGeorgios MeletisEfstathia EvangelopoulouPanagiota StyliaraIlektra KarypidouAthena GogaliKonstantinos KalafatakisNikolaos Tzanakis

Published in: International journal of chronic obstructive pulmonary disease (2022)

Aclidinium/formoterol provided significant benefits on the quality of life of COPD patients by reducing the morning, daytime and the night-time symptoms and symptom burden in GOLD Groups B-D, and activity impairment under real-life conditions in all GOLD ABCD groups.

Keyphrases

sleep quality
end stage renal disease
chronic kidney disease
ejection fraction
lung function
newly diagnosed
obstructive sleep apnea
prognostic factors
depressive symptoms
peritoneal dialysis
combination therapy
patient reported